https://www-bbc-co-uk.cdn.ampproject.org/c/s/www.b

New Post Public Reply Private Reply Replies (1) Message Board
Crunch55
880
https://www-bbc-co-uk.cdn.ampproject.org/c/s/...h-55751874

BBC News
menu
Covid-19: Scientists challenge 'flawed' lateral flow tests report
By Philippa Roxby
Health reporter
21 January 2021 Health
Share this with Email Share this with Facebook Share this with Twitter Share this with Whatsapp
Image copyrightGETTY IMAGESA lateral flow test for coronavirus
Image captionLateral flow tests are being used to test people with no symptoms in hundreds of local authorities
A group of experienced scientists has issued a statement supporting the use of lateral flow tests in the battle against Covid.

They say the rapid devices have identified 27,000 infected people in the UK who would not otherwise have had to self-isolate.

The findings of a recent report suggested the tests were inaccurate and potentially harmful.

But the scientists say that report was flawed and confused.

Signatories to the statement include Prof Calum Semple, professor of outbreak medicine and child health, from the University of Liverpool, Prof Sir John Bell, regius professor of medicine at the University of Oxford, and Dr Susan Hopkins, interim chief medical adviser from Public Health England.

They reject the accusation, in a report by Prof Jon Deeks, Dr Angela Raffle and Dr Mike Gill on 10 January, that lateral flow tests (LFT) will cause harm, saying there is no evidence for the "irresponsible" claim.

And they say the tests are fast, easy to use and an essential tool in the current epidemic.

Unfounded criticism
The scientists go on to explain that the report confused the role of PCR tests and lateral flow devices.

PCR tests, which the NHS uses to test people with symptoms and are sent off to a lab for the results, can detect dead virus as well as viable virus.

ADVERTISEMENT
That means people can test positive for many days after symptoms appear and for weeks after they are capable of passing the virus on to others.

As a result, only a subset of people testing positive with PCR tests are actively infectious.

How worrying are the new coronavirus variants?
School attendance higher than first lockdown
Rapid coronavirus test use defended
How to get a Covid test
Lateral flow tests, however, are designed to detect live virus in people with no symptoms who are highly infectious. Results are available in 30 minutes which means those who test positive can isolate quickly.

The Deeks report said a Liverpool pilot of lateral flow tests had "missed infection" in 60% of people - but the scientists say that data has been misinterpreted.

'No gold standard'
Neither PCR or lateral flow is a perfect test, but "treating PCR as a gold standard of infectiousness" is a mistake, they say.

Prof Iain Buchan, who signed the statement and is chair of public health and clinical informatics at the University of Liverpool, said the criticism of lateral flow tests came from people not involved in public health. He added that there was no review carried out of their claims before publication.

He also said the controversy over the rapid tests had affected public confidence in them, which was damaging.

The Department for Education in England has paused the rollout of daily testing of close contacts , using LFTs, in all but a small number of secondary schools and colleges.

Prof Buchan said this was to allow time for schools to organise their rollout properly.

ADVERTISEMENT
"Proper implementation can keep schools going," he said.

In England, lateral flow tests are currently being used by a number of large companies to test their workforce, in secondary schools to test staff and pupils who remain in school, and in more than 300 local authorities for testing people who cannot work from home during the lockdown.

Banner image reading 'more about coronavirus'
SCHOOLS: What will happen if children catch coronavirus?
TESTING: How do I get a virus test?
LOOK-UP TOOL: How many cases in your area?
THE R NUMBER: What it means and why it matters
TEST AND TRACE: How does it work?
Banner
More on this story

Covid: How does mass testing work?
20 January 2021


Coronavirus: How to get a Covid test
16 November 2020


'Game changer' Covid tests for secondary schools in January
15 December 2020


Covid testing of students finds few positive cases
11 December 2020


Covid: NHS rapid test use defended amid accuracy concerns
05 December 2020


Covid: Mass testing in Liverpool sees 'remarkable decline' in cases
23 November 2020

Copyright © 2021 BBC. The BBC is not responsible for the content of external sites.

Quantum Materials Corp. (QTMM) Stock Research Links

QTMM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 22

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 28

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 23

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 22

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 24

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

AI Revolutionizes Trading: Insights from FBS Analysts

Updated Category News Views 358

AI's Impact on Trading: Key Developments and Insights In recent years, artificial intelligence (AI) has significantly influenced various industries, and trading is no exception. FBS, a prominent global broker, has conducted a deep dive into this revolutionary shift. They emphasize how AI is enhancing the efficiency, accuracy, and overall decision-making processes in...

Continue Reading
Alerus Financial Corp: Anticipated Earnings Report Insights

Updated Category News Views 131

Insights into Alerus Financial Corp’s Upcoming Earnings Alerus Finl (NASDAQ: ALRS) is gearing up to share its quarterly earnings report on a forthcoming Monday. Investors are on the edge of their seats, eagerly anticipating insights into the company’s performance and forecasts for the upcoming quarter. Analysts predict that Alerus Finl will achieve an earnings per...

Continue Reading
DXC Technology Unveils London Center to Enhance AI Solutions

Updated Category News Views 133

DXC Technology Unveils New Customer Experience Center in London DXC Technology (NYSE: DXC), a prominent enterprise technology partner, has recently inaugurated its Customer Experience Center in London. This center is set to transform how businesses harness artificial intelligence (AI) by assisting them in moving from merely experimenting with AI technologies to achieving...

Continue Reading
Coave Therapeutics Showcases Innovative Capsid Technology at ESGCT

Updated Category News Views 188

Coave Therapeutics Showcases Innovative Capsid Technology at ESGCT Coave Therapeutics, a leader in genetic medicine innovation, recently presented compelling data regarding its advanced suprachoroidal capsid, coAAV-SCS-01, at the European Society of Gene and Cell Therapy Congress 2025 held in Seville. This innovative capsid has shown to outperform traditional capsids,...

Continue Reading
HealthPRO Canada Celebrates Work Culture Achievement Again

Updated Category News Views 215

HealthPRO Canada's Continued Commitment to Excellence HealthPRO Canada, a prominent provider of group contracting for healthcare, proudly announces its status as a Great Place to Work® for the fourth consecutive year. This recognition highlights the organization’s dedication to fostering a supportive and inclusive work environment. Understanding the Great Place to...

Continue Reading